Please assess the completion status of the following clinical trial:

Trial Title: SHARED Study (Saguenay Hospitals Anaphylaxis Rule for Early Discharge)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients of all ages with anaphylaxis (meeting the NIAID/FAAN criteria)~* Patients of all ages considered to be inevitably evolving torwards overt anaphylaxis by the threading physician~Exclusion Criteria:~* Adverse reaction to a medication (eg ACEI)~* Hereditary angioedema~* Known immune mediated Angioedema~* Anaphylactoid reaction

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- All anaphylaxis reactions seen during the phase 2 period of the SHARED study. (Type: None): All patients presenting to the 3 sites emergency departments (Chicoutimi, Alma, Jonquière) diagnosed with an anaphylactic reaction or a severe allergic reaction that is rapidly evolving towards anaphylaxis in the opinion of the treating physician.

Based on this trial design, predict the completion outcome and termination type (if applicable).